Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-02 4:13 pm Sale |
2025-03-31 | 13G | InMed Pharmaceuticals Inc. INM |
AdvisorShares Trust | 0 0.000% |
-1,833 (Position Closed) |
Filing History |
| 2025-01-03 4:17 pm Purchase |
2024-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
SABBY MANAGEMENT LLC | 36,135 4.900% |
34,823 (+2653.29%) |
Filing History |
| 2024-12-18 08:05 am Purchase |
2024-12-13 | 13G | InMed Pharmaceuticals Inc. INM |
YA II PN, Ltd. | 80,372 9.990% |
80,372 (New Position) |
Filing History |
| 2024-11-14 4:36 pm Purchase |
2024-09-30 | 13G | InMed Pharmaceuticals Inc. INM |
Armistice Capital, LLC | 34,816 4.990% |
33,300 (+2197.27%) |
Filing History |
| 2024-11-12 1:44 pm Purchase |
2024-09-30 | 13G | InMed Pharmaceuticals Inc. INM |
AdvisorShares Trust | 1,833 8.770% |
1,833 (New Position) |
Filing History |
| 2024-02-14 2:28 pm Purchase |
2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
Armistice Capital, LLC | 1,516 9.990% |
1,101 (+265.88%) |
Filing History |
| 2024-01-03 5:43 pm Purchase |
2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
SABBY MANAGEMENT LLC | 1,312 11.000% |
1,312 (New Position) |
Filing History |
| 2023-02-14 12:58 pm Purchase |
2022-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
Armistice Capital, LLC | 414 9.990% |
414 (New Position) |
Filing History |
| 2022-02-04 3:29 pm Purchase |
2021-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
Hudson Bay Capital Management LP | 56 3.810% |
12 (+25.99%) |
Filing History |
| 2021-02-09 4:05 pm Purchase |
2020-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
Hudson Bay Capital Management LP | 44 5.970% |
44 (New Position) |
Filing History |
| 2021-01-20 11:11 am Unchanged |
2021-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
Empery Asset Management, LP | 44 4.990% |
0 (Unchanged) |
Filing History |
| 2020-11-18 10:08 am Purchase |
2020-11-12 | 13G | InMed Pharmaceuticals Inc. INM |
Empery Asset Management, LP | 44 6.350% |
44 (New Position) |
Filing History |